Late toxicity following curative treatment of testicular cancer.
about
Two cycles of cisplatin-based chemotherapy for low-volume stage II seminoma: results of a retrospective, single-center case series.NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review.Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.Quality of life among testicular cancer survivors: a case-control study in the United StatesUnusually Located Stroke After Chemotherapy in Testicular Germ Cell Tumors.Three-Dimensional Morphology by Multiphoton Microscopy with Clearing in a Model of Cisplatin-Induced CKD.Chronic physical effects and health care utilization in long-term ovarian germ cell tumor survivors: a Gynecologic Oncology Group study.Noncancer causes of death in survivors of testicular cancer.Amifostine (WR2721) confers DNA protection to in vivo cisplatin-treated murine peripheral blood leukocytes.Long-term renal function after treatment for malignant germ-cell tumours.Toxic effects of hexaammine cobalt(III) chloride on liver and kidney in mice: Implication of oxidative stress.Correlation between retroperitoneal lymph node size and presence of metastases in nonseminomatous germ cell tumors.Prophylactic window therapy with the clinical poly(ADP-ribose) polymerase inhibitor olaparib delays BRCA1-deficient mammary tumour formation in mice.
P2860
Q33405156-10235027-5736-4E1C-B8DF-F2D645FF1C22Q34554415-B04B533E-B9F7-446B-B73A-F8979CE5FF96Q35006347-F8DDD0E2-A3B4-4A29-98E2-3A5DF593F0BAQ35146293-5FC7F620-58C8-4D4F-AFC6-B9165682E7AEQ35927651-D6F7BA7A-DB12-496A-8456-4622040C0E7BQ36746084-C774A481-9280-4A69-B2CD-CA00C84BF959Q37325094-B1AFEF40-8D15-4526-85AA-38729299D7E0Q38463130-04607E82-5D04-40ED-B220-236F93298341Q42130904-A8E01CA3-F782-422C-ADB9-2ADA8DB4FCBEQ43910346-321E4181-E70D-4CC8-9871-3D6A6FE691ACQ45963413-93624926-3D58-473C-9695-86CB39781BABQ47337330-06F3DDD5-01F8-43FA-95CA-87C1FB3A5797Q51272824-B8BCE1FB-9DF8-4D40-B607-CE60FF3E1CEF
P2860
Late toxicity following curative treatment of testicular cancer.
description
1999 nî lūn-bûn
@nan
1999 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Late toxicity following curative treatment of testicular cancer.
@ast
Late toxicity following curative treatment of testicular cancer.
@en
type
label
Late toxicity following curative treatment of testicular cancer.
@ast
Late toxicity following curative treatment of testicular cancer.
@en
prefLabel
Late toxicity following curative treatment of testicular cancer.
@ast
Late toxicity following curative treatment of testicular cancer.
@en
P2093
P2860
P1476
Late toxicity following curative treatment of testicular cancer.
@en
P2093
Bokemeyer C
Hartmann JT
Kollmannsberger C
P2860
P304
P356
10.1002/(SICI)1098-2388(199912)17:4<275::AID-SSU9>3.0.CO;2-U
P577
1999-12-01T00:00:00Z